908 Devices Inc.

908 Devices Inc. reported FY 2025 revenue of $56.2 million, an increase from $47.7 million in FY 2024. The company achieved a net income attributable to common stockholders of $19.5 million, a significant improvement from a net loss of $72.2 million in the prior year. This result was driven by a $52.8 million net gain from discontinued operations related to the sale of the Desktop Portfolio, which offset a $33.3 million net loss from continuing operations. Gross profit was $28.4 million, with a gross margin of 50.6%. The company ended the year with $70.5 million in cash and cash equivalents and $42.5 million in marketable securities, providing a strong liquidity position. The sale of the Desktop Portfolio represents a strategic shift, allowing the company to focus on its handheld chemical analysis devices.

Key Takeaways